Rate My Professor Charlotte Oyston

Charlotte Oyston is a Senior Lecturer in the Department of Obstetrics and Gynaecology within the Faculty of Medical and Health Sciences at the University of Auckland. She concurrently practices as an Obstetrician at Middlemore Hospital, Te Whatu Ora Counties Manukau. Her academic qualifications include a BMedSci (Hons), MBChB, Postgraduate Diploma in Obstetrics and Medical Gynaecology (PGDipOMG), PhD, and Fellowship of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (FRANZCOG). Oyston's PhD, completed at the Liggins Institute, University of Auckland, investigated therapies for fetal growth restriction and was supported by the DHS scholarship.

Oyston's research specializations are diabetes in pregnancy, perinatal mortality, preeclampsia, and fetal growth restriction. She serves as principal investigator for projects including the Continuous Glucose Monitoring study for pregnant people with type 2 diabetes and the Baby heAd Elevation Device (BEAD) feasibility study. She contributes to multi-centre trials such as C*STEROID, evaluating corticosteroids for threatened preterm birth, and Mi-labourTrial, assessing mifepristone for vaginal birth after caesarean. With 44 publications and 469 citations on ResearchGate, her key works include 'Therapeutic strategies for the prevention and treatment of pre-eclampsia and fetal growth restriction' (2020, Progress in Obstetrics and Gynaecology), 'Pregnancy outcomes in women with booking HbA1c ≤ 40 mmol/mol: An observational study' (2021, Australian and New Zealand Journal of Obstetrics and Gynaecology), 'Factors associated with postpartum contraceptive planning and uptake at Middlemore Hospital: A quality improvement project' (2023, Contraception), 'Telehealth and Technology for Diabetes in Pregnancy Clinics: A Quality Improvement Initiative' (2024, International Journal of Telemedicine and Applications), 'Mifepristone versus placebo to increase the rate of successful vaginal birth after caesarean section: protocol for a double-blind randomised controlled trial (Mi-labourTrial)' (2025), and 'The Tubo-ovarian abscess study (TOAST): A single-center experience' (2025, International Journal of Gynaecology and Obstetrics). Accredited as a PhD/doctoral supervisor, she engages in teaching and student supervision in obstetrics and gynaecology. Her contributions enhance clinical management and outcomes in high-risk pregnancies through evidence-based research and quality initiatives.